ClinicalTrials.govpublic full text
Stroke Risk Assessment and Markers of Blood Clotting in Patients With Newly Diagnosed Non-valvular Atrial Fibrillation (NVAF), Who Have Not Received Oral Anticoagulation Therapy (OAC-therapy) Prior to Inclusion
atrial fibrillation (af), atrial fibrillation (prevention of stroke), atrial fibrillation new onset, non valvular atrial fibrillation, stroke (in patients with atrial fibrillation), stroke
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 444801
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.